Accretion Nutraveda Limited (BOM:544694)

India flag India · Delayed Price · Currency is INR
186.00
+4.50 (2.48%)
At close: Mar 9, 2026
44.19%
Market Cap 1.35B
Revenue (ttm) 160.49M
Net Income (ttm) 26.13M
Shares Out 7.24M
EPS (ttm) 7.19
PE Ratio 25.87
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,000
Average Volume 76,450
Open 181.50
Previous Close 181.50
Day's Range 181.00 - 186.00
52-Week Range 129.00 - 208.00
Beta n/a
RSI 59.95
Earnings Date n/a

About Accretion Nutraveda

Accretion Nutraveda Limited manufactures and sells ayurvedic and nutraceutical products in India and Internationally. The company specializes in ayurvedic and nutraceutical products including tablets, capsules, oral liquids, oral powders, external preparations, and oils. Its product portfolio includes tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support; capsules, including hard gelatin and HPMC capsules, targeting areas like liver detoxification,... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 2021
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544694
Full Company Profile

Financial Performance

In fiscal year 2025, Accretion Nutraveda's revenue was 160.49 million, an increase of 216.62% compared to the previous year's 50.69 million. Earnings were 26.13 million, an increase of 217.90%.

Financial Statements

News

There is no news available yet.